ArticleMikrochimica acta2026
Boronate-mediated antibody orientation: a molecular simulation-guided strategy for ultra-sensitive lateral flow immunoassays.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The random immobilization of antibodies on lateral flow immunoassay (LFIA) strips remains a major factor limiting assay sensitivity and consistency. To address this, we report a boronate affinity-based strategy for site-specific antibody orientation via covalent reaction between boronic acid and cis-diol groups on Fc-region glycans. Molecular dynamics simulations provided mechanistic support for this design. The boronate-antibody configuration demonstrated the most favorable binding energy (- 153.93 kJ/mol) and the fastest conformational stabilization (< 40 ns), suggesting a stabilization process involving initial electrostatic guidance followed by hydrogen-bond and covalent bond formation. Experimentally, this oriented immobilization achieved an antibody conjugation efficiency of 99.92%, a Fab exposure rate of 47.52% and significantly improved functional activity, with an affinity constant of 0.93 × 10⁸ M⁻¹, outperforming conventional passive adsorption. Applied to the detection of zearalenone (ZEN) in corn, the oriented LFIA showed a dramatic sensitivity enhancement. The limit of detection reached 0.049 µg/kg, 200-fold higher than traditional colloidal gold LFIA. The visual cut-off value was 0.5 µg/kg. Validation with spiked and naturally contaminated samples yielded recoveries of 84.7%-103.4% (CV: 7.1%-12.6%) and excellent correlation (R
Indexed as
Identifiers
42579021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.